Symbols

MANE

VeraDermics·NYSE

--(--)

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About MANE

Veradermics, Incorporated

Industry

Biological Technology

Established Date

10/05/2019

Listing Date

02/04/2026

Exchange

New York Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.veradermics.com

Security Type

Common stock

Office address

470 James St. New Haven CT 06513

Business

Introduction

VeraDermics, Incorporated was founded on October 5, 2019, originally located in Texas, and was converted to a Delaware company on September 15, 2021. This late-stage clinical-stage biopharmaceutical company, founded by a dermatologist, focuses on developing innovative therapies for prevalent aesthetic and dermatological conditions. VeraDermics focuses on addressing the challenges of patterned alopecia (PHL) treatment that affects numerous individuals in the United States. The Company is currently advancing its lead drug candidate, VDPHL 01, an oral non-hormonal treatment designed to optimize hair growth while minimizing side effects associated with traditional therapies. VeraDermics is conducting pivotal clinical trials to support regulatory approval and, through its targeted treatment approach, aims to change the way PHL is managed.